Comparing Prices of Daily and As-Needed Cialis
The efficacy and safety of CIALIS for once daily use for the treatment
| Method | Description | Estimated Savings ($/month) | Notes |
|---|---|---|---|
| Buying Generic Tablets | Switch to generic version | 10-15 | Significantly cheaper |
| Bulk Purchase | Purchase monthly supplies at once | 5-10 | Includes discounts |
| Online Pharmacies | Use online licensed pharmacies | 8-12 | Price comparison recommended |
| Insurance Reimbursement | Use insurance plans | Varies | Depends on plan |
of ED, and the signs and symptoms ofBPH, in patients with both conditions
Understanding Tadalafil
Patients were encouraged to make 4 separate attempts at their assigned dose and assigned timepoint. In this study, the results demonstrated a statistically significant difference between the placebo group and the CIALIS groups at each of the pre-specified timepoints. At the 24-hour timepoint, the mean, per patient percentage of attempts resulting in successful intercourse were 42, 56, and 67% for the placebo, CIALIS 10-, and 20-mg groups, respectively. At the 36-hour timepoint, the mean, per-patient percentage of attempts resulting in successful intercourse were 33, 56, and 62% for placebo, CIALIS 10-, and20-mg groups, respectively. The efficacy and safety of CIALIS for once daily use in the treatment of erectile dysfunction has been evaluate din 2 clinical trials of 12-weeks duration and 1 clinical trial of 24-weeks duration, involving a total of 853patients.
Book a Cialis prescription request appointment.
CIALIS, when taken once daily, was shown to be effective in improving erectile function in men with erectile dysfunction (ED). CIALIS was studied in the general ED population in 2 randomized, multicenter, double-blinded, placebo-controlled, parallel-arm design, primary efficacy and safety studies of 12- and 24-weeks duration, respectively.One of these studies was conducted in the United States and one was conducted in centers outside the US. An additional efficacy and safety study was performed in ED patients with diabetes mellitus. CIALIS was taken once daily at doses ranging from 2.5 to 10 mg. Food and alcohol intake were not restricted. was evaluated in one placebo-controlled, multinational,
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Cialis Generic | 5mg | 20 Pills | 41.99€ 39.99€ | |
| Cialis Super Active | 20mg | 180 + 20 Pills | 521.59€ 496.75€ | |
| Cialis Generic | 20mg | 60 + 6 Pills | 117.76€ 112.15€ | |
| Cialis Generic | 20mg | 90 + 6 Pills | 154.71€ 147.34€ | |
| Cialis Soft Tabs | 20mg | 270 + 10 Pills | 471.40€ 448.95€ | |
| Cialis Super Active | 20mg | 120 + 16 Pills | 382.15€ 363.95€ | |
| Cialis Super Active | 20mg | 10 Pills | 55.64€ 52.99€ | |
| Cialis Professional | 40mg | 180 + 4 Pills | 618.23€ 588.79€ | |
| Cialis Professional | 20mg | 20 Pills | 78.33€ 74.60€ | |
| Cialis Professional | 20mg | 180 + 4 Pills | 423.11€ 402.96€ | |
| Cialis Generic | 40mg | 180 + 10 Pills | 277.29€ 264.09€ | |
| Cialis Super Active | 20mg | 30 + 6 Pills | 128.09€ 121.99€ | |
| Cialis Original | 20mg | 34 + 2 Pills | 183.99€ 175.23€ |
double-blind, parallel-arm study which randomized 606 patients
- Buying Cialis from approved online pharmacies can ensure safety and better prices.
- The cost may be affected by geographical location and local drug laws.
- Subscription services may provide discounted rates for daily Cialis supplies.
- Generic versions of Cialis are approved and tested for safety and efficacy.
to receive either CIALIS 2.5 mg, 5 mg, for once daily use or placebo.
Is generic Cialis (tadalafil) as potent as brand name Cialis?
The IPSS assesses the severity of irritative (frequency, urgency, nocturia) and obstructive symptoms (incomplete emptying, stopping and starting, weak stream, and pushing or straining), with scores ranging from 0 to 35; higher numeric scores representing greater severity. Maximum urinary flow rate (Qmax),an objective measure of urine cialis help with premature ejaculation flow, was assessed as a secondary efficacy endpoint in Study J and as a safety endpoint in Study K. The results for BPH patients with moderate to severe symptoms and a mean age of 63.2 years (range 44 to 87)who received either CIALIS 5 mg for once daily use or placebo (N=748) in Studies J and K are shown in Table19 and Figures 5 and 6 , respectively. In each of these 2 trials, CIALIS 5 mg for once daily use resulted in statistically significant improvement in the total IPSS compared to placebo. Mean total IPSS showed a decrease starting at the first scheduled observation(4 weeks) in Study K and remained decreased through 12 weeks.
4. Compare costs with other ED pills
Table 19: Mean IPSS Changes in BPH Patients in Two CIALIS for Once Daily Use Studies Figure 5: Mean IPSS Changes in BPH Patients by Visit in Study J Figure 6: Mean IPSS Changes in BPH Patients by Visit in Study K In Study J, the effect of CIALIS 5 mg once daily on maximum urinary flow rate (Qmax) was evaluated as a secondary efficacy endpoint. Mean Qmax increased from baseline in both the treatment and placebo groups(CIALIS 5 mg: 1.6 mL/sec, placebo: 1.2 mL/sec); however, these changes were not significantly different between groups. In Study K, the effect of CIALIS 5 mg once daily on Qmax was evaluated as a safety endpoint. Mean Qmax increased from baseline in both the treatment and placebo groups (CIALIS 5 mg: 1.6 mL/sec, placebo:1.1 mL/sec); however, these changes were not significantly different between groups. CIALIS for once daily use initiated together with finasteride was shown to be effective in treating the signs and symptoms of BPH in men with an enlarged prostate (>30 cc) for up to 26 weeks. ED severity ranged from mild to severe and BPH severity ranged from moderate to severe.
- Misconceptions: Cialis does not increase sexual desire; it aids erection.
- It is not an aphrodisiac and requires sexual stimulation to work.
- Higher dose does not necessarily mean better results; follow prescription.
- Daily use does not lead to dependency in a addictive sense.
- Generic is not inferior; it has same active ingredient and efficacy.
- Cost does not always correlate with quality; generics are bioequivalent.
- ED is not just an older man's issue; young men can be affected.
- Treatment is not only about sex; it can improve overall quality of life.
- Natural does not always mean safer; some supplements have risks.
- Online pharmacies claiming no prescription are often illegal and dangerous.
- Cialis does not protect against sexually transmitted infections.
The full study population had a mean age of 63 years (range 45 to 83) and was 93% White, 4% Black, 3% other races;16% were of Hispanic ethnicity.
- The average cost of daily Cialis can vary widely depending on the source.
- Some telemedicine services provide direct-to-patient Cialis at reduced prices.
- Long-term use might qualify for special discounts or price plans.
- Researching and planning purchases can help maintain affordability for daily use.
In this study, the co-primary endpoints were total IPSS and the
What the Tadalafil science says
This additional double-blinded, parallel-design study of 26 weeks duration randomized 696 men to initiate either CIALIS 5 mg with finasteride 5 mg or placebo with finasteride 5mg. The study population had a mean age of 64 years (range 46-86). Patients with multiple co-morbid conditions such as erectile dysfunction, diabetes mellitus, hypertension, and other cardiovascular disease were included. CIALIS with finasteride demonstrated statistically significant improvement in the signs and symptoms of BPHcompared to placebo with finasteride, as measured by the total IPSS at 12 weeks, the primary study endpoint( see Table 20). Key secondary endpoints demonstrated improvement in total IPSS starting at the first scheduled observation at week 4 (CIALIS -4.0, placebo -2.3: p<.001) and the score remained decreased through 26 weeks(CIALIS -5.5, placebo -4.5; p=.022).
7. What other health conditions do you have?
However, the magnitude of the treatment difference between placebo/finasteride and CIALIS/finasteride decreased from 1.7 points at Week 4 to 1.0 point at Week 26, as shown in Table 20 and in Figure 7 . The incremental benefit of CIALIS beyond 26 weeks is unknown. Table 20: Mean Total IPSS Changes in BPH Patients in a CIALIS for Once Daily Use Study Together with Finasteride Figure 7: Mean Total IPSS Changes By Visit in BPH Patients Taking CIALIS for Once Daily Use In the 404 patients who had both ED and BPH at baseline, changes in erectile function were assessed as key secondary endpoints using the EF domain of the IIEF questionnaire. CIALIS with finasteride (N=203) was compared to placebo with finasteride (N=201). A statistically significant improvement from baseline(CIALIS/finasteride 13.7, placebo/finasteride 15.1) was observed at week 4 (CIALIS/finasteride 3.7,placebo/finasteride -1.1; p<.001), week 12 (CIALIS/finasteride 4.7, placebo/finasteride 0.6; p<.001), and week 26 (CIALIS/finasteride 4.7, placebo/finasteride 0.0; p<.001). Erectile Function (EF) domain score of theInternational Index of Erectile Function (IIEF).
- Ethical considerations: Pharmaceutical profits vs. patient access debate.
- Marketing tactics sometimes overhype benefits while downplaying risks.
- Doctors may receive incentives to prescribe brand-name over generic.
- Privacy concerns with online pharmacies selling patient data.
- Animal testing involved in development raises ethical questions.
- Access disparities between rich and poor highlight healthcare inequality.
- Environmental justice issues near manufacturing plants affect communities.
- Truthfulness in advertising about efficacy and cost is regulated.
- Patient autonomy in choosing treatment versus doctor recommendations.
- Cultural sensitivity in marketing to diverse populations is important.
- Fair pricing models that ensure R&D funding without gouging patients.
One of the key secondary endpoints in this study
| Cost Tier | Price Range ($) | Features | Suitable For |
|---|---|---|---|
| Budget | 30-40 | Generic, online purchase | Cost-conscious users |
| Standard | 45-60 | Branded, pharmacy purchase | Regular users needing reliable medication |
| Premium | 65-80 | Brand-name, specialty pharmacy | Users requiring high quality or specific formulations |
was Question3 of the Sexual Encounter Profile diary (SEP3).
| Effectiveness Level | Average Cost per Month ($) | Success Rate (%) | Cost per Success ($) | Notes |
|---|---|---|---|---|
| High | 50 | 85 | 58.82 | Consistent daily use proven effective |
| Moderate | 30 | 70 | 42.86 | Less consistent but effective for some |
| Low | 60 | 50 | 120.00 | Less effective, higher cost per outcome |
The efficacy results for patients with both ED and BPH, who received either CIALIS 5 mg for
Drug Interactions for Cialis
Timing of sexual activity was not restricted relative to when patients took Cialis. The primary US efficacy and safety trial included a total of 287 patients ,with a mean age of 59 years (range 25 to 82 years). The population was 86% White, 6% Black, 6% Hispanic, and 2% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, andother cardiovascular disease. Most (>96%) patients reported ED of at least 1-year duration. The primary efficacy and safety study conducted outside the US included 268 patients, with a mean age of 56years (range 21 to 78 years).
Alternatives for benign prostatic hyperplasia (BPH)
The population was 86% White, 3% Black, 0.4% Hispanic, and 10% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease.Ninety-three percent of patients reported ED of at least 1-year duration. In each of these trials, conducted without regard to the timing of dose and sexual intercourse, CIALISdemonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary ( see Table 17). When taken as directed, CIALIS was effective at improving erectile function. In the 6 month double-blind study, the treatment effect of CIALIS did not diminish over time. Table 17: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in the TwoCIALIS for Once Daily Use Studies CIALIS for once daily use was shown to be effective in treating ED in patients with diabetes mellitus. once daily use or placebo (N=408) are shown in Tables 21 and 22 and Figure 8 .
Who Can and Cannot take tadalafil?
Patients with diabetes were included in both studies in the general ED population (N=79). A third randomized, multicenter, double-blinded, placebo-controlled, parallel-arm design trial included only ED patients with type 1 or type 2 diabetes (N=298). In this third trial, CIALISdemonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary ( see Table 18). Table 18: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in a CIALIS forOnce Daily Use Study in ED Patients with Diabetes The efficacy and safety of CIALIS for once daily use for the treatment of the signs and symptoms of BPH was evaluated in 3 randomized, multinational, double-blinded, placebo-controlled, parallel-design, efficacy and safety studies of 12 weeks duration. Two of these studies were in men with BPH and one study was specific to men with both ED and BPH [see CIALIS 5 mg For Once Daily Use For ED And BPH] .
Carina Fung, PharmD, BCPPS
The first study (Study J) randomized 1058 patients to receive either CIALIS 2.5 mg, 5 mg, 10 mg or 20 mg for once daily use or placebo. The second study (Study K) randomized 325 patients to receive either CIALIS 5 mg for once daily use or placebo. The full study population was 87% White, 2% Black, 11% other races; 15% was of Hispanic ethnicity. Patients with multiple co-morbid conditions such as diabetes mellitus, hypertension, and other cardiovascular disease were included. The primary efficacy endpoint in the two studies that evaluated the effect of CIALIS for the signs and symptoms of BPH was the International Prostate Symptom Score (IPSS), a four week recall questionnaire that was administered at the beginning and end of a placebo run-in period and subsequently at follow-up visits after randomization.